Showing results (121-130 of 191) with videos related to

Sort By:
Pageof 20
British Journal of Haematology|August 30, 2008
Genome-wide DNA analysis identifies recurrent imbalances predicting outcome in chronic lymphocytic leukaemia with 17p deletionFrancesco Forconi, Andrea Rinaldi, Ivo Kwee, et al.
European Journal of Haematology|May 14, 2026
To Treat or Not to Treat: Navigating Early-Stage CLL in the Era of Targeted TherapyEnrica Antonia Martino, Santino Caserta, Ernesto Vigna, et al.
Hematological Oncology|October 3, 2012
Clinical heterogeneity of de novo 11q deletion chronic lymphocytic leukaemia: prognostic relevance of extent of 11q deleted nuclei inside leukemic cloneRoberto Marasca, Rossana Maffei, Silvia Martinelli, et al.
Leukemia|June 18, 2025
Measurement of Immunoglobulin Intraclonal diversification refines the clinical impact of IGHV mutational status in chronic lymphocytic leukemiaFilippo Vit, Tamara Bittolo, Antonella Zucchetto, et al.
Leukemia & Lymphoma|March 18, 2010
Molecular and clinical features of chronic lymphocytic leukemia with stereotyped B-cell receptors in a Ukrainian cohortNadiia Bilous, Riccardo Bomben, Michele Dal Bo, et al.
Plos One|June 6, 2014
Endothelin-1 promotes survival and chemoresistance in chronic lymphocytic leukemia B cells through ETA receptorRossana Maffei, Jenny Bulgarelli, Stefania Fiorcari, et al.
British Journal of Haematology|July 14, 2011
Genome-wide DNA profiling better defines the prognosis of chronic lymphocytic leukaemiaAndrea Rinaldi, Michael Mian, Ivo Kwee, et al.
British Journal of Haematology|April 3, 2004
CD90/Thy-1 is preferentially expressed on blast cells of high risk acute myeloid leukaemiasFrancesco Buccisano, Francesca Maria Rossi, Adriano Venditti, et al.
Haematologica|August 5, 2018
Bromodomain and extra-terminal domain inhibition modulates the expression of pathologically relevant microRNAs in diffuse large B-cell lymphomaAfua A Mensah, Luciano Cascione, Eugenio Gaudio, et al.
British Journal of Haematology|February 10, 2011
B-cell receptor, clinical course and prognosis in chronic lymphocytic leukaemia: the growing saga of the IGHV3 subgroup gene usageMichele Dal-Bo, Ilaria Del Giudice, Riccardo Bomben, et al.
Pageof 20